You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

 

Online download statistics by month:

Online download statistics by month: December 2019 to May 2022

AbstractFullPdf
Dec 2019110
Jan 2020550
Feb 202022229
Mar 2020313117
Apr 202028289
May 202029292
Jun 2020262613
Jul 202032321
Aug 202022221
Sep 2020323211
Oct 202035356
Nov 2020282810
Dec 202015157
Jan 202132328
Feb 2021494917
Mar 2021454517
Apr 2021464722
May 2021404014
Jun 202140406
Jul 2021474714
Aug 2021434310
Sep 2021424224
Oct 2021282812
Nov 2021232310
Dec 202143438
Jan 202244467
Feb 202234357
Mar 202232326
Apr 202227297
May 2022767911
Total9971006286